F-Prime Capital β 2024 Investments
9 investments dated 2024 Β· listed companies and verified rows first Β· show all
Denali Therapeutics develops therapeutics for neurodegenerative diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Marc Tessier-Lavigne(Director)Ryan Watts(Executive Officer, Director)Alexander O. Schuth(Executive Officer)Carole Ho(Executive Officer)Steve E. Krognes(Director)
BoardDavid P. Schenkein(Director)in
Co-investorsARCH Venture PartnersEcoR1 CapitalForesite CapitalGV (Google Ventures)
Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women.
BiotechFemTechHealthtechConcord, US
Mike Young(Founder)T Scott Johnson(Founder)inPaul Antinori(Executive Officer)Allison August(Executive Officer)Michael Young(Executive Officer)Thomas Scott Johnson(Executive Officer, Director)
Board seatMuz MansuriKetan PatelΒ· per SEC Form D
Co-investorsAtlas VentureGV (Google Ventures)Broadview VenturesLilly Asia VenturesNew Enterprise Associates (NEA)
Walnut, US
Roberto Cebrian Flores(Executive Officer, Director)David Villarreal Ortiz(Executive Officer, Director)
Board seatDavid JegenΒ· per SEC Form D Β· $5M raise Β· filed Feb 2024
TripSuite is a software platform for travel agencies that combines CRM, commission tracking, accounting, itinerary management, analytics, and workflow automation in one system.
SaaSTravel & HospitalityBrooklyn, US
Jacey Jones(Executive Officer, Director, Promoter)Christopher John Graves(Executive Officer, Director, Promoter)
Board seatGaurav TuliΒ· per SEC Form D
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(Founder/CTO)inNick Damiano(Executive Officer, Director)John Beck(Executive Officer)
BoardBryan Kim(Director)Blayne Roeder(Director)
Board seatRobert WeisskoffΒ· per SEC Form D
Co-investorsAstiaShangBay Capital LLCY CombinatorDorm RoomGolden SeedsMedical Technology Venture Partners
Burro builds autonomous robots for agricultural and outdoor operations that mow, tow, carry, and spray to automate manual labor tasks.
AgTechAI & Machine LearningRobotics
Terry Scott(Founder)
Co-investorsAsimov VenturesCatalyst InvestorsEverywhere VenturesNextFab VenturesRadicle GrowthS2G Investments+4 more
Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.
HealthtechMiami Lakes, US
Carlos D. Bustamante(Executive Officer, Director)Arthur Polk(Executive Officer)Alexander Ioannidis(Director)
BoardWale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)
Co-investorsCEI VenturesCitta CapitalFounder CollectiveFunction VenturesHelios Digital VenturesLifeX Ventures+2 more
Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.
BiotechHealthtechMedical DevicesWatertown, US
MATTHEW FRANKEL(Executive Officer)PETER COUROSSI(Executive Officer)RICHARD BATYCKY(Executive Officer, Director)JAMES ELLIS(Executive Officer)MICHAEL LIPP(Executive Officer)CHRISTOPHER SILBER(Executive Officer)
Co-investorsCanaan PartnersMission BiocapitalMonograph Capital PartnersOUP (Osage University Partners)Osage University Partners
Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Michael V. McConnell(Chief Health Officer and Interim CEO)inFrancesca Logan(Chief Commercial Officer)inYariv Levin(Chief Compliance, Ethics and Clinical Affairs Officer)in
Co-investorsArc AngelsIcehouse VenturesOutset VenturesBlockchain CapitalFunders Club Managementgmjp+6 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.